HomeCERO • NASDAQ
add
CERo Therapeutics Holdings Inc
Previous close
$10.68
Day range
$9.55 - $10.66
Year range
$6.71 - $895.40
Market cap
4.93M USD
Avg Volume
2.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.11M | 12.19% |
Net income | -5.11M | -122.03% |
Net profit margin | — | — |
Earnings per share | -31.80 | — |
EBITDA | -5.03M | -13.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.20M | 13.29% |
Total assets | 7.99M | -11.72% |
Total liabilities | 8.32M | -36.15% |
Total equity | -329.39K | — |
Shares outstanding | 386.10K | — |
Price to book | -1.00 | — |
Return on assets | -179.84% | — |
Return on capital | -3,555.59% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.11M | -122.03% |
Cash from operations | -4.45M | 12.49% |
Cash from investing | — | — |
Cash from financing | 6.32M | -11.67% |
Net change in cash | 1.88M | -9.69% |
Free cash flow | -2.14M | -139.61% |
About
Founded
2020
Headquarters
Website
Employees
8
